Company Filing History:
Years Active: 2023-2025
Title: Innovations of Jun Yeul Lim in Pharmaceutical Formulations
Introduction
Jun Yeul Lim is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of modified interleukin-7 fusion proteins. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of Jun Yeul Lim's latest patents involves a pharmaceutical formulation comprising a modified IL-7 protein. This formulation includes a modified IL-7 fusion protein, a basal buffer with a concentration of 10 to 50 mM, a sugar with a concentration of 2.5 to 5 w/v %, and a surfactant with a concentration of 0.05 to 6 w/v %. This innovative formulation does not show aggregates formation and demonstrates protective effects on proteins under stress conditions such as oxidation or agitation. Therefore, it can be effectively used for the treatment of patients.
Career Highlights
Jun Yeul Lim is currently associated with Genexine, Inc., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in protein formulations has positioned him as a key player in the industry.
Collaborations
He has collaborated with notable coworkers such as Donghoon Choi and Changyong Eun, contributing to the advancement of their shared goals in pharmaceutical research.
Conclusion
Jun Yeul Lim's innovative work in the formulation of modified interleukin-7 fusion proteins showcases his dedication to improving patient care through advanced pharmaceutical solutions. His contributions are significant in the ongoing evolution of medical treatments.